Why the study?
To evaluate serial changes of CT-FFR and FAI and examine their relationships with long-term clinical outcomes.
Do serial changes in CT-FFR and FAI predict major adverse cardiac events in symptomatic patients with intermediate pretest probability of CAD and 30-70% coronary stenosis?
Cohort (n=263)
Do serial changes in CT-FFR and FAI predict major adverse cardiac events in symptomatic patients with intermediate pretest probability of CAD and 30-70% coronary stenosis?
Serial changes in CT-FFR and FAI provide incremental prognostic value over conventional clinical and imaging parameters for risk stratification in patients with intermediate coronary stenosis.
BACKGROUND: To investigate the serial changes of computed tomography (CT) fractional flow reserve (CT-FFR) and fat attenuation index (FAI), and explore their relationships with long-term clinical outcomes. METHODS: Consecutive symptomatic patients with an intermediate pretest probability of coronary artery disease 1-4 were prospectively enrolled if coronary CT angiography (CCTA) revealed at least 1 lesion with 30-70% stenosis on major epicardial arteries. Follow-up CCTA was performed at 1 to 1.5-year intervals. All patients were further followed up after the second CCTA until September 2019. The Coronary Artery Disease - Reporting and Data System (CAD-RADS) grade, high-risk plaque features, lesion-specific CT-FFR, and FAI were measured for prognosis analysis. RESULTS: A total of 263 patients were included in the analysis, and 38 major adverse cardiac events (MACEs) occurred. In the MACE group, the lesion-specific CT-FFR decreased significantly at the follow-up CCTA [0.80 (0.74-0.90) versus 0.85 (0.76-0.93); P=0.01], whereas the FAI did not notably increase (-70.4±8.9 versus -71.3±7.1 HU; P=0.436). In the non-MACE group, lesion-specific CT-FFR increased markedly [0.91 (0.84-0.95) versus 0.90 (0.82-0.94); P<0.001], while the FAI decreased substantially (-74.0±10.8 versus -72.4±11.5 HU; P=0.004). Decreased CT-FFR (adjusted overall hazard ratio =2.455; P=0.023) and increased FAI (adjusted hazard ratio =2.956; P=0.002) were the strongest independent predictors of MACEs. Serial changes of CT-FFR and FAI provided incremental prognostic value (Concordance statistic =0.716; P=0.003; over conventional clinical and imaging parameters (Concordance statistic =0.762; P=0.004). CONCLUSIONS: Decreased CT-FFR and increased FAI at follow-up CCTA were the 2 strongest predictors of MACEs. Serial changes of CT-FFR and FAI provided incremental prognostic value over conventional clinical and imaging parameters for risk stratification. In addition, decreased CT-FFR provided incremental predictive value for MACEs from 15 months after second CCTA, while increased FAI added prognostic value from the second CCTA onwards.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2021) conducted a cohort in Coronary artery disease (n=263). Decreased CT-FFR and increased FAI vs. Stable or improved CT-FFR and FAI was evaluated on Major adverse cardiac events (MACEs) (HR 2.455, p=0.023).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: